• Jasion VS, Burnett BP. Survival and digestibility of orally- administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans. Nutr J. 2015;14:22. Published 2015 Mar7. doi:10.1186/s12937- 015-0010-7 
  • Petschow BW, Burnett B, Shaw AL, Weaver EM, Klein GL. Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy. Clin Exp Gastroenterol. 2014;7:181-190. Published 2014 May 24. doi:10.2147/CEG.S62823 
  • Ulfman LH, Leusen JHW, Savelkoul HFJ, Warner JO, van Neerven RJJ. Effects of Bovine Immunoglobulins on Immune Function, Allergy, and Infection. Front Nutr. 2018 Jun 22;5:52. doi: 10.3389/fnut.2018.00052. PMID: 29988421; PMCID: PMC6024018.
  • Petschow, Bryon W et al. “Serum-derived bovine immunoglobulin/protein isolate: postulated mechanism of action for management of enteropathy.” Clinical and experimental gastroenterology vol. 7 181-90. 24 May. 2014, doi:10.2147/CEG.S62823
  • Utay, Netanya S et al. “Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19.” Drug development research vol. 82,7 (2021): 873-879. doi:10.1002/ddr.21841


  • Front. Endocrinol., 31 January 2020 |
  • den Besten G, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013; 54(9): 2325-2340. 
  • Russo E, Giudici F, Fiorindi C, Ficari F, Scaringi S, Amedei A. Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease. Front Immunol. 2019 Nov 22;10:2754. doi: 10.3389/fimmu.2019.02754. PMID: 31824517; PMCID: PMC6883404.
  • Cleophas, M.C.P., Ratter, J.M., Bekkering, S. et al. Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males. Sci Rep 9, 775 (2019).
  • Scarpellini, E., Lauritano, E.C., Lupascu, A., Petruzzellis, C., Novi, M., Roccarina, D., Gabrielli, M., Serricchio, M., Gasbarrini, G.B., & Gasbarrini, A. (2007). Efficacy of butyrate in the treatment of diarrhoea-predominant irritable bowel syndrome. Digestive and Liver Disease Supplements, 1, 19-22.
  •  Roberto Berni Canani, Margherita Di Costanzo and Ludovica Leone.  The epigenetic effects of butyrate: potential therapeutic implications for clinical practice.  Clinical Epigenetics 2012, 4:4.

Bacillus coagulans SNZ 1969®, Bacillus subtilis SNZ 1972 and Bacillus clausii SNZ 1971:

  • Soman RJ, Swamy MV. A prospective, randomized, double- blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort. Int J Colorectal Dis. 2019;34(11):1971-1978.doi:10.1007/s00384-019-03416-w 
  • Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol. 2009;31(10):655-659.doi:10.1358/mf.2009.31.10.1441078 
  • Gabrielli M, Lauritano EC, Scarpellini E, Lupascu A, Ojetti V, Gasbarrini G, Silveri NG, Gasbarrini A. Bacillus clausii as a treatment of small intestinal bacterial overgrowth. Am J Gastroenterol. 2009 May;104(5):1327-8. doi: 10.1038/ ajg.2009.91. Epub 2009 Apr 7. PMID: 19352343. 


  • T.C. Chang, etc. Effect of Ginsenosides on Glucose Uptake in Human Caco-2 Cells Is Mediated through Altered Na Glucose Cotransporter 1 Expression. J. of Agric. and Food Chemistry. 2007, 55, 1993-1998. 
  • S.F. Huang, etc. Effect of Ginsenoside Rb1 on Glucose Uptake and Expression of Glucose Transporter in Animal Cells. University of Manitoba, Canada. April, 2010. 
  • S.Y. Lee, etc. Astragaloside II promotes intestinal epithelial repair by enhancing L-arginine uptake and activating the mTOR pathway. Scientific Reports. Sept., 2017. 


  • Kim M, Benayoun BA. The microbiome: an emerging key player in aging and longevity. Transl Med Aging. 2020;4:103-116. Epub 2020 Jul 21. PMID: 32832742; PMCID: PMC7437988.